Actazin® 600mg US/Canada clinical study is now published!

Here’s the final piece of your Actazin® inside NPD puzzle!

Are you interested in developing natural remedies to improve digestive health? Our second clinical study highlights the remarkable benefits of Actazin®, a green kiwifruit powder, in relieving occasional constipation and promoting a healthy gut.

Icon: low dose

Actazin® Dose: 600 mg

Icon: group of people

Sample size: 85 participants

Icon: calendar

Study length: 28 days

Paper’s Highlights

Close-up of sliced green kiwifruit

Green kiwifruit fibre may provide natural laxation benefits.

Substantiation of the benefits of 600 mg daily Actazin® with a larger participant pool of 85

Digital scale weighing a small dish of kiwifruit powder

We ran a 28-day randomized, placebo-controlled, double-blinded parallel study.

Futuristic blue graphic with circular icons representing clinical research
Child in pink pyjamas sitting on a toilet holding toilet paper

Actazin® gave clinically significant improvements in stool form and improved bowel habits

Fecal microbiome changes were consistent with eating plant cell wall polysaccharides.

Microscope view of green plant cells

Significant Improvement in Bowel Function

The study demonstrated that a daily intake of 600 mg of Actazin® significantly improved bowel function in healthy individuals with occasional constipation.

Participants experienced a notable improvement in stool form, as measured by the Bristol Stool Form Score (BSFS), and an increase in the number of complete spontaneous bowel movements (CSBM).

Positive Impact on Gut Microbiota

Consumption of Actazin® led to changes in the relative abundance of fecal bacterial taxa, indicating potential benefits to gut microbiota.

These changes were consistent with the consumption of kiwifruit cell wall components, suggesting that Actazin® not only improves bowel function but also supports a healthy gut ecosystem.

Well-Tolerated and Effective at a Lower Dose

Actazin® was effective and well-tolerated at a lower dose of 600 mg per day.

The study showed that this dosage led to significant improvements without causing significant adverse effects, making it a convenient and practical solution for maintaining regular bowel habits.

Written by Emma Graham, Starin Mckeen, Doug Rosendale and others.

Headshot of an Anagenix team member

Emma Graham

Product Champion – Actazin®/Livaux®

Headshot of an Anagenix team member

Starin Mckeen

Product Champion  | Anagenix Ltd.

Headshot of an Anagenix team member

Doug Rosendale

Chief Science Officer | Anagenix Ltd.

You can directly ask them all your questions and concerns about your NPD process.

Download the paper here

Don’t miss out on these groundbreaking insights—download the paper today and take a step towards better digestive wellness!

Published paper on Actazin green kiwifruit powder at 600 mg per day for occasional constipation